Author: Scribner Richard Johnson Sandy Cohen Deborah Robinson William Farley Thomas Gruenewald Paul
Publisher: Informa Healthcare
ISSN: 1082-6084
Source: Substance Use & Misuse, Vol.43, Iss.2, 2008-01, pp. : 203-221
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Etravirine for the treatment of HIV/AIDS
Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 8, 2013-06 ,pp. :
Nanomedicines as Therapeutics in HIV-AIDS
Pharmaceutical Nanotechnology, Vol. 4, Iss. 4, 2016-12 ,pp. :
Access to HIV/AIDS drugs widens
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 334, 2001-01 ,pp. :
Funding boost for HIV/AIDS initiatives
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 358, 2002-01 ,pp. :
Pharma giants commit to HIV/AIDS effort
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 369, 2002-01 ,pp. :